Effects of caveolin-1 and P-ERK1/2 on Ang II-induced glomerular mesangial cell proliferation

Renal Failure

Volumn 35, Issue 7, 2013, Pages 971-977

  Zhang, Na ^a   Ji, Zequan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Caveolin 1; ERK1 2; Glomerular mesangial cell; TRPC6

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; CAVEOLIN 1; M BETA CD; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAVEOLA; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GLOMERULUS EPITHELIUM; IMMUNOCYTOCHEMISTRY; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; CAVEOLIN 1; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MESANGIAL CELLS; RATS; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS;

EID: 84880254071     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.808956     Document Type: Article

References (27)

1. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev. 2003; 23(1):15-31.
2. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308(5729):1801-1804.
3. Liu Y, Ji Z. FK506 alleviates proteinuria in rats with adriamycininduced nephropathy by down-regulating TRPC6 and CaN expressions. J Nephrol. 2012;25(6):918-925.
4. Gudermann T. A new TRP to kidney disease. NAT Genet. 2005; 37(7):663-664.
5. Qiu G, Ji Z. AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration. Clin Exp Med. 2013; Mar 5. [Epub ahead of print].
6. Bakris GL, Weir MR, Secic M, et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int. 2004;65(6):1991-2002.
7. Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrinol Rev. 2001;22(2):153-183.
8. Yatabe J, Sanada H, Yatabe MS, et al. Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol. 2009;296(5): F1052-F1060.
9. Gorin Y, Ricono JM, Wagner B, et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J. 2004;381(PT 1):231-239.
10. Tamai O, Oka N, Kikuchi T, et al. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int. 2001;59(2):471-480.
11. Bardell TK, Barker EL. Activation of TRPC6 channels promotes endo-cannabinoid biosynthesis in neuronal CAD cells. Neurochem Int. 2010;57(1):76-83.
12. Pereira LG, Arnoni CP, Maquigussa E, et al. (Pro)renin receptor: another member of the system controlled by angiotensin II? J Renin Angiotensin Aldosterone Syst. 2012;13(1):1-10.
13. Ji Z, Huang C, Liang C, et al. Protective effects of blocking reninangiotensin system on the progression of renal injury in glomerulosclerosis. Cell Mol Immunol 2005;2(2):150-154.
14. Qu LP, Xue H, Yuan P, et al. Adenosine 50-triphosphate stimulates the increase of TGF-beta1 in rat mesangial cells under highglucose conditions via reactive oxygen species and ERK1/2. Acta Pharmacol Sin. 2009;30(12):1601-1606.
15. Bergdahl A, Gomez MF, Dreja K, et al. Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing storeoperated Ca2+ entry dependent on TRPC1. Circ Res. 2003;93: 839-847.
16. Fielding CJ, Fielding PE. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta. 2003;1610(2):219-228.
17. Peng F, Wu D, Ingram AJ, et al. RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction. J Am Soc Nephrol. 2007;18(1):189-198.
18. Zeidan A, Broman J, Hellstrand P, et al. Cholesterol dependence of vascular ERK1/2 activation and growth in response to stretch: role of endothelin-1. Arterioscler Thromb Vasc Biol. 2003; 23(9):1528-1534.
19. Quest AF, Leyton L, Párraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004;82(1):129-144.
20. Razani B, Lisanti MP. Caveolins and caveolae: molecular and functional relationships. Exp Cell Res. 2001;271(1):36-44.
21. Yamamoto M, Toya Y, Schwencke C, et al. Caveolin is an activator of insulin receptor signaling. J Biol Chem. 1998;273(41): 26962-26968.
22. Wang X, Feng S, Zhang H, et al. RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERa) signaling in human mammary epithelial cells. Mol Biol Rep. 2011;38(2):761-768.
23. Pancotti F, Roncuzzi L, Maggiolini M, et al. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling. Cell Signal. 2012;24(7):1390-1397.
24. Fujita Y, Maruyama S, Kogo H, et al. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Kidney Int. 2004;66(5):1794-1804.
25. Terada Y, Nakashima O, Inoshita S, et al. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int. 1999;56(4):1378-1390.
26. Bokemeyer D, Guglielmi KE, McGinty A, et al. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest. 1997;100(3):582-588.
27. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52(1):11-34. School of Education Department of Guangdong Province